A

Alivio Therapeutics

2 employees

Alivio Therapeutics is pioneering a new way to treat inflammatory diseases based on precisely tuning the immune system.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Medical
Health Care

Date founded

2016

Funding rounds raised

Total raised

$3.3M

from 1 investors over 1 rounds

A

Alivio Therapeutics raised $3.3M on September 12, 2018

Investors: united-states-department-of-defense

FAQ